查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1527275

全球药品合约包装市场规模研究，依产品类型、形式类型、应用类型和区域预测 2022-2032

Global Pharmaceutical Contract Packaging Market Size Study, by Product Type, by Form Type, by Application Type and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球药品合约包装市场价值约为61亿美元，预计在2024-2032年预测期内将以超过7.5%的健康成长率成长。药品合约包装是将药品的包装流程外包给专业的第三方公司，由其提供泡罩包装、装瓶、贴标和二次包装等服务。这使得製药公司能够专注于药物开发和行销等核心活动，同时确保遵守监管标准。合约包装商提供包装技术、品质控制和供应链管理的专业知识，有助于降低成本、提高效率并确保整个分销过程中的产品安全和完整性。

日益严格的品质要求以及将药品包装外包给新兴国家的合约包装商预计将在预测期内推动市场发展。製药公司正在将包装活动外包给合约包装商，以降低整体生产成本并加快上市速度。预计这将有助于预测期内市场的成长。此外，缺乏内部包装能力、专业知识和预算限制是该行业小型製药公司面临的主要问题。由于提供低成本服务，合约包装服务提供者被认为是遏制小型公司此类问题的有效方法。然而，资源和预算的缺乏促使许多小型製药公司与合约包装组织（CPO）和合约开发和製造组织（CDMO）建立互惠互利的关係。合约服务提供者正在做出重大尝试，以满足客户的期望并提供高度复杂的包装设施。此外，全球不断成长的製药业预计将推动市场发展。由于包装活动外包提供了多种好处，例如获得先进的包装技术、提高效率、专注于核心领域、获得熟练的资源以及更快更好的服务，因此製药公司越来越多地将包装服务外包给CPO 和CDMO。

美国药品供应链安全法案（DSCSA）和欧盟伪造药品衍生性商品法案（FMD）等序列化的实施，强制要求在药品包装上使用条码，并在药品供应过程中传输大量资料。这使得製造公司开发适当的基础设施来遵守这项新立法。序列化的引入预计将在预测期内推动市场发展。技术创新、人口成长、健康意识、先进製造技术的实施、公共卫生系统支出的增加以及政府实施控制传染病传播的新法规都是推动成长的因素。此外，对生物产品以及基因和细胞疗法等新疗法的需求不断增长，有助于促进製药公司的发展，从而增加对此类包装产品的需求。

北美透过合约产生了全球对有效药品包装解决方案近三分之一的需求，占据了领先的市场份额。根据计算，光是美国地区产生的总收入就占北美总业务的 90% 左右。总部位于美国的 CPO 和 CDMO 提供的优质服务推动了该国对药品合约包装服务和解决方案的需求。对生物疗法的需求、严格方案的增加以及老年人口的增加也可能扩大全球药品合约包装市场规模。然而，由于该地区存在大量合约包装服务提供商，预计亚太地区在预测期内将出现最快的成长。这些参与者正致力于扩大其设施，以满足製药公司不断增长的需求。此外，增加药品製造外包给印度等新兴国家正在进一步推动该地区市场的成长。

目录

第 1 章：全球药品合约包装市场执行摘要

  • 全球药品合约包装市场规模及预测（2022-2032）
  • 区域概要
  • 分部摘要
    • 依产品类型
    • 依表格类型
    • 按应用程式类型
  • 主要趋势
  • 经济衰退的影响
  • 分析师推荐与结论

第 2 章：全球药品合约包装市场定义与研究假设

  • 研究目的
  • 市场定义
  • 研究假设
    • 包容与排除
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者的角度）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者意识和接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第 3 章：全球药品合约包装市场动态

  • 市场驱动因素
    • 日益严格的品质要求
    • 不断发展的製药业
    • 对仿製药的需求
  • 市场挑战
    • 缺乏内部包装能力
    • 小型製药公司的预算限制
  • 市场机会
    • 包装技术创新
    • 对生物产品和新疗法的需求不断增长

第 4 章：全球药品合约包装市场产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
    • 波特五力模型的未来方法
    • 波特的五力影响分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：全球药品合约包装市场规模与预测：依产品类型 - 2022-2032

  • 细分仪表板
  • 全球药品合约包装市场：2022 年和 2032 年产品类型收入趋势分析
    • 软包装
    • 塑胶或玻璃容器
    • 盖子或封口

第 6 章：全球药品合约包装市场规模与预测：按形式类型 - 2022-2032

  • 细分仪表板
  • 全球药品合约包装市场：2022 年和 2032 年形式类型收入趋势分析
    • 口服
    • 可注射

第 7 章：全球药品合约包装市场规模与预测：按应用类型 - 2022-2032

  • 细分仪表板
  • 全球药品合约包装市场：2022 年和 2032 年应用类型收入趋势分析
    • 自体酸及相关药物
    • 避孕药具
    • 荷尔蒙替代品
    • 心血管药物
    • 癌症治疗

第 8 章：全球药品合约包装市场规模及预测：按地区 - 2022-2032

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 9 章：竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • Catalent Pharma Solutions
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • Patheon
    • Baxter BioPharma Solutions
    • AbbVie Contract Manufacturing
    • Pfizer Centre Source
    • Daito Pharmaceutical
    • Nipro Corporation
    • Becton Dickinson & Company
    • AptarGroup Inc.
    • Drug Plastics Group

第 10 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
简介目录

The Global Pharmaceutical Contract Packaging Market is valued approximately at USD 6.1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2024-2032. Pharmaceutical contract packaging involves outsourcing the packaging process of pharmaceutical products to specialized third-party companies, which provide services such as blister packing, bottling, labelling, and secondary packaging. This allows pharmaceutical companies to focus on core activities like drug development and marketing while ensuring compliance with regulatory standards. Contract packagers offer expertise in packaging technology, quality control, and supply chain management, helping to reduce costs, enhance efficiency, and ensure product safety and integrity throughout the distribution process.

Increasing stringent quality requirements and outsourcing of pharmaceutical packaging to contract packagers in emerging countries are expected to drive the market over the forecast period. Pharmaceutical companies are outsourcing the packaging activities to contract packagers to reduce the overall cost of production and speed to market. This is anticipated to contribute to the growth of the market over the forecast period. In addition, lack of in-house packaging capabilities, expertise, and budget constraints are the major issues faced by small pharmaceutical companies in the industry. Contract packaging service providers are recognized as an effective approach to curb such issues of the small companies owing to the low-cost service offering. However, lack of resources and budgets has prompted many small pharmaceutical companies to establish mutually beneficial relationships with Contract Packaging Organizations (CPOs) and Contract Development and Manufacturing Organizations (CDMOs). Contract service providers are making significant attempts to meet their client's expectations and provide highly sophisticated packaging facilities. Moreover, the growing pharmaceutical industry across the globe is anticipated to drive the market. As outsourcing of packaging activities offers several benefits such as access to advanced packaging technologies, increased efficiency, focus on core areas, access to skilled resources, and faster and better services, pharmaceutical companies are increasingly outsourcing the wrapping services to the CPOs and CDMOs.

The implementation of serialization including the Drug Supply Chain Security Act (DSCSA) in the U.S. and the EU Falsified Medicines Derivative (FMD) has mandated the barcodes on pharmaceutical packaging and the transfer of large volumes of data in the supply of medicines. This has made manufacturing companies develop appropriate infrastructure to comply with this new legislation. The introduction of serialization is expected to drive the market over the forecast period. Technological innovations, population increase, health awareness, the implementation of advanced manufacturing techniques, higher spending in public health systems, and the government implementation of new regulations to control the transmission of contagious diseases are all contributing factors to the growth. Furthermore, the growing demand for bio-products and new treatments such as gene and cell therapies are helpful to promote the pharmaceutical companies thereby increasing the demand for such packaging products.

North America accounts for the leading market share by generating almost one-third of the global demand for effective pharmaceutical packaging solutions through contracts. The total revenue generated by the United States alone was figured out to be around 90% of the total business in North America. Quality services offered by the CPOs and CDMOs based in the United States propel the demand for pharmaceutical contract packaging services and solutions in the country. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population could also broaden the global pharma contract packaging market size. However, Asia Pacific is expected to witness the fastest growth over the forecast period due to the presence of a large number of contract packaging service providers in the region. These players are focusing on expanding their facilities to satisfy the growing needs of pharmaceuticals companies. In addition, increasing the outsourcing of pharmaceutical manufacturing to emerging countries such as India is further driving the growth of the market in the region.

Major market players included in this report are:

  • Catalent Pharma Solutions
  • Patheon
  • Baxter BioPharma Solutions
  • AbbVie Contract Manufacturing
  • Pfizer Centre Source
  • Daito Pharmaceutical
  • Nipro Corporation
  • Becton Dickinson & Company
  • AptarGroup Inc.
  • Drug Plastics Group
  • Gerresheimer AG
  • Schott AG
  • Owens Illinois Inc.
  • WestRock Company SGD S.A.
  • International Paper Company

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Flexible Packaging
  • Plastic or Glass Containers
  • Caps or Closures

By Form Type:

  • Oral
  • Injectable

By Application Type:

  • Autacoids & Related Drugs
  • Contraceptives
  • Hormone Replacement
  • Cardiovascular Medicines
  • Cancer Therapies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Pharmaceutical Contract Packaging Market Executive Summary

  • 1.1. Global Pharmaceutical Contract Packaging Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Form Type
    • 1.3.3. By Application Type
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Pharmaceutical Contract Packaging Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Contract Packaging Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increasing Stringent Quality Requirements
    • 3.1.2. Growing Pharmaceutical Industry
    • 3.1.3. Demand for Generic Pharmaceuticals
  • 3.2. Market Challenges
    • 3.2.1. Lack of In-house Packaging Capabilities
    • 3.2.2. Budget Constraints for Small Pharmaceutical Companies
  • 3.3. Market Opportunities
    • 3.3.1. Technological Innovations in Packaging
    • 3.3.2. Rising Demand for Bio-products and New Treatments

Chapter 4. Global Pharmaceutical Contract Packaging Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Pharmaceutical Contract Packaging Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Flexible Packaging
    • 5.2.2. Plastic or Glass Containers
    • 5.2.3. Caps or Closures

Chapter 6. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Form Type 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Pharmaceutical Contract Packaging Market: Form Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Oral
    • 6.2.2. Injectable

Chapter 7. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Application Type 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Pharmaceutical Contract Packaging Market: Application Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Autacoids & Related Drugs
    • 7.2.2. Contraceptives
    • 7.2.3. Hormone Replacement
    • 7.2.4. Cardiovascular Medicines
    • 7.2.5. Cancer Therapies

Chapter 8. Global Pharmaceutical Contract Packaging Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Pharmaceutical Contract Packaging Market
    • 8.1.1. U.S. Pharmaceutical Contract Packaging Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Form Type breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application Type breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Pharmaceutical Contract Packaging Market
  • 8.2. Europe Pharmaceutical Contract Packaging Market
    • 8.2.1. UK Pharmaceutical Contract Packaging Market
    • 8.2.2. Germany Pharmaceutical Contract Packaging Market
    • 8.2.3. France Pharmaceutical Contract Packaging Market
    • 8.2.4. Spain Pharmaceutical Contract Packaging Market
    • 8.2.5. Italy Pharmaceutical Contract Packaging Market
    • 8.2.6. Rest of Europe Pharmaceutical Contract Packaging Market
  • 8.3. Asia Pacific Pharmaceutical Contract Packaging Market
    • 8.3.1. China Pharmaceutical Contract Packaging Market
    • 8.3.2. India Pharmaceutical Contract Packaging Market
    • 8.3.3. Japan Pharmaceutical Contract Packaging Market
    • 8.3.4. Australia Pharmaceutical Contract Packaging Market
    • 8.3.5. South Korea Pharmaceutical Contract Packaging Market
    • 8.3.6. Rest of Asia Pacific Pharmaceutical Contract Packaging Market
  • 8.4. Latin America Pharmaceutical Contract Packaging Market
    • 8.4.1. Brazil Pharmaceutical Contract Packaging Market
    • 8.4.2. Mexico Pharmaceutical Contract Packaging Market
    • 8.4.3. Rest of Latin America Pharmaceutical Contract Packaging Market
  • 8.5. Middle East & Africa Pharmaceutical Contract Packaging Market
    • 8.5.1. Saudi Arabia Pharmaceutical Contract Packaging Market
    • 8.5.2. South Africa Pharmaceutical Contract Packaging Market
    • 8.5.3. Rest of Middle East & Africa Pharmaceutical Contract Packaging Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Catalent Pharma Solutions
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Patheon
    • 9.3.3. Baxter BioPharma Solutions
    • 9.3.4. AbbVie Contract Manufacturing
    • 9.3.5. Pfizer Centre Source
    • 9.3.6. Daito Pharmaceutical
    • 9.3.7. Nipro Corporation
    • 9.3.8. Becton Dickinson & Company
    • 9.3.9. AptarGroup Inc.
    • 9.3.10. Drug Plastics Group

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes